Salmeterol Xinafoate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Salmeterol Xinafoate is used to treat asthma and bronchial spasm, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 4, 1994. In 2024, Medicare Part D spent $37 million on Salmeterol Xinafoate across 62,000 claims for 16,000 beneficiaries.
Salmeterol Xinafoate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $6.74 to $6.74 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$6.74 – $6.74
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SALMETEROL XINAFOATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SEREVENT DISKUS 50 MCG | $6.7443 per EA | 0.00% |
Frequently Asked Questions
What is Salmeterol Xinafoate used to treat?
Salmeterol Xinafoate is used to treat asthma and bronchial spasm, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Salmeterol Xinafoate?
In 2024, Medicare Part D spent $37 million on Salmeterol Xinafoate across 62,000 claims for 16,000 beneficiaries.
How many Salmeterol Xinafoate products are on the market?
The Salmeterol Xinafoate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Salmeterol Xinafoate?
NADAC reference prices for Salmeterol Xinafoate range from $6.7443 to $6.7443 per EA.
Which manufacturers make Salmeterol Xinafoate?
1 manufacturer lists Salmeterol Xinafoate in NADAC. Ranked by number of NDCs, the largest are GlaxoSmithKline LLC (1).
How has the price of Salmeterol Xinafoate changed recently?
Over the past 7 days, 0 Salmeterol Xinafoate NDCs rose and 0 fell, with a market-wide average change of +0.0%.